| |
|
|
|
Arrowhead Conferences, Doubletree Hotel, Philadelphia, PA
February 22 - 24
At Arrowhead’s 2010 Personalized Medicine Partnerships Conference, we will highlight key issues in forming partnerships and engage the best speakers to share their experiences with you. These key issues include: - what pharmaceutical and diagnostic companies are looking for in a partner
- partnering challenges that arise within the realm of contractual negotiations, IP protection, regulatory affairs and commercialization
- benefits of partnerships, including more effective, efficient and safer clinical trials
- how and when to start a relationship, ie. discovery, clinical, post-commercialization?
- the risks of partnering
among many other interesting topics. You will also have multiple chances to network and meet with others in the industry during one-to-one meetings and networking breaks and receptions. There will also be an online networking tool available before the conference even begins! http://www.personalizedmedicinepartnerships.com/index.php?option=com_content&view=article&id=22&Itemid=29
|
|
|
|
|
|
|
|
Organized by:
|
|
Arrowhead Conferences |
|
|
Invited Speakers:
|
|
SPEAKERS
Christopher Austin, MD Director, NIH Chemical Genomics Center National Human Genome Institute Stafford O'Kelly President Abbott Molecular
Elizabeth Mansfield, Ph.D. Sr. Director, Genomics and Personalized Medicine FDA Office of the Commissioner
Cecilia Schott, PharmD., MBA Business Development Director, Personalized Healthcare, Strategic Planning and Business Development AstraZeneca
Linda Egger, Ph.D. Director, Scientific Liaison Merck & Co.
Patrick Terry CEO Technic Solutions Co-Founder Genomic Health Founder Personalized Medicine Coalition
William Welch Former Sr Vice President, Chief Commercial Officer Monogram Biosciences (LabCorp)
Charles Raffin VP Commercial Assessment, Worldwide Franchise Development Ortho Clinical Diagnostics (Johnson & Johnson)
Jason Coloma, Ph.D. Head of Strategic Partnering Roche Molecular Diagnostics
John A. Norris, JD, MBA Former Chief Operating Officer FDA Chairman and Chief Executive Officer Norris Capital, Inc. Chief Operating Officer Health Discovery Corporation
Stephen Barnhill, MD Chairman and Chief Executive Officer Health Discovery Corporation
Mara G. Aspinall President and CEO On-Q-ity Vice Chairman Personalized Medicine Coalition former President Genzyme Genetics
Dr. Stephen Little Vice President Personalized Healthcare Qiagen Manchester (DxS Diagnostic Innovations)
Mohan S. Iyer Chief Business Officer Tethys Bioscience
Iain D. Miller, Ph.D. Senior Director, Oncology Strategy and Theranostics bioMérieux
Gerald J. McDougall Partner in Charge of Personalized Medicine and Health Sciences Practices PriceWaterhouseCoopers
Ryan Phelan CEO and Founder DNA Direct
David S. Lester, Ph.D. VP Human Health Solutions Theranos
Manohar Furtado, Ph.D. Distinguished Scientific Fellow Life Technologies (Applied Biosystems)
Bryan Dechairo, Ph.D. Senior Director, Development Head Personalized Medicine Medco
Brian Buxton Principal Easton Associates Peter Keeling CEO Diaceutics, Inc.
Keith Batchelder, MD Chief Executive Officer and Founder Genomic Healthcare Strategies
Joseph Ferrara President Boston Healthcare Associates
Harry Glorikian Managing Partner Scientia Advisors
Peter Miller Chief Operating Officer Genomic Healthcare Strategies
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
http://www.regonline.com/Checkin.asp?EventId=792401
|
|
|
E-mail:
|
|
marketing@personalizedmedicinepartnerships.com
|
|
|
|
|
|
|
|
|